Pain Therapeutics reported $2.97M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Acelrx Pharmaceuticals ACRX:US $ 6.82M 516K
Amgen AMGN:US $ 1.33B 99M
Biogen BIIB:US $ 572.6M 62.3M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Eisai 4523:JP 92.31B 18.18B
Eli Lilly And LLY:US $ 1.63B 67.2M
Geron GERN:US $ 7.44M 744K
Johnson & Johnson JNJ:US $ 6.23B 288M
Merk MRK:US $ 2.42B 118M
Novartis NOVN:VX 3.59B 91M
Novavax NVAX:US $ 108.16M 12.17M
Pain Therapeutics PTIE:US $ 2.97M 54K
Pfizer PFE:US $ 3.2B 506M